Literature DB >> 19271108

Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis.

T Hayton1, J Furby, K J Smith, D R Altmann, R Brenner, J Chataway, R A C Hughes, K Hunter, D J Tozer, D H Miller, R Kapoor.   

Abstract

Although there is substantial brain grey matter pathology in secondary progressive multiple sclerosis (MS), there has been limited investigation of its contribution to disability.This study investigated the correlation of magnetization transfer ratio (MTR) measures taken from brain grey matter, normal appearing white matter (NAWM) and lesions with neurological deficit and disability in 113 people with secondary progressive MS. In order to adjust for the potential effects of focal white matter lesions and global brain atrophy, T2 lesion volume and normalized brain volume (NBV) were also calculated for each subject. Clinical measures included the expanded disability status scale (EDSS) and the multiple sclerosis functional composite (MSFC) scores. Linear regression analysis was used to assess the age- and gender-adjusted correlation of MTR histogram mean, peak height and peak location with the MSFC and individual component measures. Logistic regression analysis was used to determine whether imaging measures could be used to predict if subjects were in the higher disability group (EDSS > or = 6.5).Significant correlations were detected between MSFC composite and mean MTR in (i) normal appearing white matter (NAWM; r = 0.327, p < 0.0001), (ii) grey matter (r = 0.460, p < 0.0001) and (iii) lesions (r = 0.394, p < 0.0001). Although NBV and T2 lesion volume correlated significantly with MSFC, grey matter histogram mean emerged as the best predictor of MSFC score. None of the MRI measures significantly predicted higher EDSS.These results suggest that brain grey matter pathology plays an important role in determining neurological impairment. The apparent paucity of correlation between MRI measures and EDSS is likely to represent the relative insensitivity of the latter measure in this study group.

Entities:  

Mesh:

Year:  2009        PMID: 19271108     DOI: 10.1007/s00415-009-0110-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  46 in total

1.  Axonal changes in chronic demyelinated cervical spinal cord plaques.

Authors:  G Lovas; N Szilágyi; K Majtényi; M Palkovits; S Komoly
Journal:  Brain       Date:  2000-02       Impact factor: 13.501

2.  Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load.

Authors:  Mario Quarantelli; Andrea Ciarmiello; Vincenzo Brescia Morra; Giuseppe Orefice; Michele Larobina; Roberta Lanzillo; Vittorio Schiavone; Elena Salvatore; Bruno Alfano; Arturo Brunetti
Journal:  Neuroimage       Date:  2003-02       Impact factor: 6.556

3.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

4.  Multimodal image coregistration and partitioning--a unified framework.

Authors:  J Ashburner; K Friston
Journal:  Neuroimage       Date:  1997-10       Impact factor: 6.556

5.  MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability.

Authors:  D K B Li; U Held; J Petkau; M Daumer; F Barkhof; F Fazekas; J A Frank; L Kappos; D H Miller; J H Simon; J S Wolinsky; M Filippi
Journal:  Neurology       Date:  2006-05-09       Impact factor: 9.910

6.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo.

Authors:  S D Wolff; R S Balaban
Journal:  Magn Reson Med       Date:  1989-04       Impact factor: 4.668

7.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration.

Authors:  L Bø; C A Vedeler; H Nyland; B D Trapp; S J Mørk
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

8.  Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.

Authors:  Frederik Barkhof; Wolfgang Bruck; Corline J A De Groot; Elisabeth Bergers; Sandra Hulshof; Jeroen Geurts; Chris H Polman; Paul van der Valk
Journal:  Arch Neurol       Date:  2003-08

9.  Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study.

Authors:  L Ramió-Torrentà; J Sastre-Garriga; G T Ingle; G R Davies; V Ameen; D H Miller; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

10.  Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

Authors:  D T Chard; C M Griffin; G J M Parker; R Kapoor; A J Thompson; D H Miller
Journal:  Brain       Date:  2002-02       Impact factor: 13.501

View more
  11 in total

Review 1.  Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.

Authors:  Christian Enzinger; Frederik Barkhof; Olga Ciccarelli; Massimo Filippi; Ludwig Kappos; Maria A Rocca; Stefan Ropele; Àlex Rovira; Torben Schneider; Nicola de Stefano; Hugo Vrenken; Claudia Wheeler-Kingshott; Jens Wuerfel; Franz Fazekas
Journal:  Nat Rev Neurol       Date:  2015-11-03       Impact factor: 42.937

Review 2.  MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy.

Authors:  Massimo Filippi; M A Rocca
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-31       Impact factor: 3.825

3.  Magnetization transfer imaging in premanifest and manifest Huntington disease.

Authors:  S J A van den Bogaard; E M Dumas; J Milles; R Reilmann; J C Stout; D Craufurd; M A van Buchem; J van der Grond; R A C Roos
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

4.  Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis.

Authors:  T Hayton; J Furby; K J Smith; D R Altmann; R Brenner; J Chataway; K Hunter; D J Tozer; D H Miller; R Kapoor
Journal:  J Neurol       Date:  2011-08-24       Impact factor: 4.849

5.  Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine.

Authors:  T Hayton; J Furby; K J Smith; D R Altmann; R Brenner; J Chataway; K Hunter; D J Tozer; D H Miller; R Kapoor
Journal:  J Neurol       Date:  2011-09-09       Impact factor: 4.849

Review 6.  Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.

Authors:  Daniel Ontaneda; Robert J Fox; Jeremy Chataway
Journal:  Lancet Neurol       Date:  2015-02       Impact factor: 44.182

7.  Abnormal functional connectivity and cortical integrity influence dominant hand motor disability in multiple sclerosis: a multimodal analysis.

Authors:  Jidan Zhong; Julia C Nantes; Scott A Holmes; Serge Gallant; Sridar Narayanan; Lisa Koski
Journal:  Hum Brain Mapp       Date:  2016-07-06       Impact factor: 5.038

Review 8.  Advances in multiple sclerosis research in 2009.

Authors:  Stefan Nessler; Wolfgang Brück
Journal:  J Neurol       Date:  2010-08-06       Impact factor: 4.849

Review 9.  Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.

Authors:  Timothy Vollmer; Lynn Huynh; Caroline Kelley; Philip Galebach; James Signorovitch; Allitia DiBernardo; Rahul Sasane
Journal:  Neurol Sci       Date:  2015-11-04       Impact factor: 3.307

Review 10.  Clinical correlates of grey matter pathology in multiple sclerosis.

Authors:  Dana Horakova; Tomas Kalincik; Jana Blahova Dusankova; Ondrej Dolezal
Journal:  BMC Neurol       Date:  2012-03-07       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.